Albert Bourla

Albert Bourla

executive United States

Albert Bourla is the CEO of Pfizer, a leading global pharmaceutical company. He gained significant recognition for his leadership during the COVID-19 pandemic, particularly for spearheading the rapid development of the vaccine. Recently, he has indicated Pfizer's focus on oral medications for obesity treatments, acknowledging the company's late entry into the injectable space.

Born on Oct 21, 1961 (64 years old)

Global Media Ratings
Dominance
0.00%
Persistence
0 wks
Reach
4,692
Power
5$
Sentiment
7.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
Ireland 1 7.00 0.09% +0% 5,030,000 4,692 $5,100 5$
Totals 1 5,030,000 4,692 $5,100 5$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

Slovenia Slovenia: Albert Bourla is the CEO of Pfizer who was involved in communications with Ursula von der Leyen during the vaccine procurement process. 5

Delo – major Slovenian daily, est. 1959: Sodišče zavrglo tožbo proti Ursuli von der Leyen zaradi afere Pfizer

Pakistan Pakistan: Albert Bourla, CEO of Pfizer, has supported Trump's nomination for the Nobel Prize based on the Operation Warp Speed initiative. 6

Daily Jang: ٹرمپ کی خواہش پوری ہوگی یا دل ٹوٹے گا؟

Taiwan Taiwan: Trump announced a deal with Pfizer Inc CEO Albert Bourla to cut drug prices in exchange for relief from planned tariffs. 6

Taipei Times – major English newspaper in Taiwan, est. 1999: Trump targets economic deals before midterm votes

Guatemala Guatemala: Albert Bourla stated that the agreement is historic and aims to reverse an unjust situation. 8

Prensa Libre – major Guatemalan newspaper, est. 1951: los detalles del acuerdo entre el presidente de EE. UU. y Pfizer

Guyana Guyana: Pfizer CEO Albert Bourla was present during Trump's announcement regarding drug prices. 6

Stabroek News: Pfizer does deal with Trump on prescription drug prices